RF
MDGL icon

Rossby Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rossby Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3K Buy
+10
New +$4.78K ﹤0.01% 1476
2025
Q3 		– Sell
-1,048
Closed -$317K – 1504
2025
Q2 		$317K Hold
1,048
– – 0.12% 180
2025
Q1 		$342K Hold
1,048
– – 0.14% 146
2024
Q4 		$323K Buy
+1,048
New +$295K 0.2% 130

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rossby Financial's MDGL Position: Q1 2026 in Review

Rossby Financial opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 10 shares worth $5.3K. The stake represents ﹤0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Rossby Financial previously reported a position in MDGL as recently as Q2 2025.

Rossby Financial first reported a position in MDGL in Q4 2024 and has held it in 4 quarters since. The position peaked at $342K in Q1 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Rossby Financial held 10 shares of Madrigal Pharmaceuticals worth $5.3K as of Q1 2026.
  • Madrigal Pharmaceuticals was a new Rossby Financial position in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q1 2026, its #1476 holding.
  • Rossby Financial first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Rossby Financial's Madrigal Pharmaceuticals position peaked at $342K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.